Skip to main content

Canavan Disease clinical trials at UCSF

1 research study open to eligible people

Canavan disease is a rare brain disorder. UCSF is studying a new treatment called BBP-812, which uses AAV9 gene therapy. The main goal of this trial is to test the safety and effects of this new therapy.

Showing trials for

Our lead scientists for Canavan Disease research studies include .

Last updated: